The National Football League Alumni Association, Cancer Treatment Centers of America® and LabCorp Team Up to Offer Prostate Cancer Screenings Starting this September
ZION, Ill., Aug. 30, 2017 - Prostate cancer is the most common cancer among men. In an effort to increase awareness of the disease and the benefits of early screening, the National Football League Alumni Association (NFLA), Cancer Treatment Centers of America® (CTCA) and LabCorp® are teaming up to educate men and increase access to screenings. Beginning Sept. 1 through Oct. 15, 2,000 men, ages 40 and older, who meet eligibility requirements, may sign up to receive a free Prostate Specific Antigen (PSA) screening by LabCorp at any of its 1,750 locations throughout the U.S. After the first 2,000 free PSA screening spots are filled, eligible men may still schedule a screening at the discounted price of $25 throughout the sign-up period. Screenings must be performed within six months of the sign-up date.
With one in seven men predicted to be diagnosed with prostate cancer in their lifetime, the American Cancer Society estimates there will be 161,360 new prostate cancer diagnoses in 2017. Experts recommend that men who are considered high-risk get screened beginning at age 40. Risk factors include family history and race, with African-American men having a more than 70 percent higher likelihood of developing prostate cancer.
As part of the Prostate Pep Talk campaign (www.prostatepeptalk.com), public service announcements featuring legendary former NFL head coaches Herm Edwards, Dick Vermeil, and Bill Cowher will raise awareness of prostate cancer risks and encourage men to get screened for the disease. The public service announcements will air nationally throughout September, which is Prostate Cancer Awareness Month.
A national kick-off press conference was held Aug. 30 at 1 p.m. ET at NFL Films in Mount Laurel, New Jersey, with Edwards and former defensive back and five-time Emmy award winner Beasley Reece. Also speaking at the event will be former NFL players, Mike Quick and Jon Runyan. Quick's father battled prostate cancer for several years and Runyan, a former U.S. Representative, is a strong prostate cancer awareness advocate.
Additionally, a local event was held in conjunction with CTCA® at Midwestern Regional Medical Center. The event included:
• A meet and greet with former Chicago Bears player Dan Hampton
• Q+A with Kamal Patel, MD, Medical Director of Radiation Oncology at CTCA at Midwestern
• LabCorp stations for eligible men to register for one free PSA screening
• Interaction with US Too, a prostate cancer education and support network
"Our best defense against prostate cancer is patient awareness," Patel said. "We are overjoyed to work with the NFLA and LabCorp to raise mindfulness about the importance of screening, as well as educate men about their options following a diagnosis."
"LabCorp is pleased to team up with the NFLA and Cancer Treatment Centers of America to increase awareness of prostate cancer and provide free and reduced-cost PSA screenings," said Gary M. Huff, CEO of LabCorp Diagnostics. "The Prostate Pep Talk campaign will help to improve health and improve lives for men across the country. Getting a PSA screening will help men and their loved ones make more informed monitoring and treatment decisions."
For more information visit Prostate Pep Talk at www.prostatepeptalk.com.
About the NFL Alumni Association
The NFL Alumni Association is a nationwide group of former NFL players, coaches, staffers, cheerleaders, spouses and associate members whose mission is to serve, assist and inform former players and their families. The Association offers a variety of medical, financial and social programs to help members lead healthy, productive and connected lives, as well as community initiatives under its "Caring for Kids" programs. For more information please visit www.nflalumni.org.
About LabCorp
LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of nearly $9.5 billion for 2016 through the contributions of 52,000 employees in approximately 60 countries. To learn more about LabCorp, visit www.labcorp.com, and to learn more about Covance Drug Development, visit www.covance.com.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America Global, Inc. (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-informed supportive therapies designed to help patients physically and emotionally by enhancing their quality of life while managing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Reflecting our patient-centered approach to cancer care, our patient satisfaction scores consistently rank among the highest in the country for cancer care providers, and CTCA is also rated one of the most admired hospital systems in the country in national consumer surveys. For more information, visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter.